Misuse-resistive transdermal opioid dosage form
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Sep 22, 1992
Grant Date -
N/A
app pub date -
Jun 14, 1991
filing date -
Jun 14, 1991
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
A misuse-resistive dosage form for the transdermal delivery of opioid comprises, in combination, 1) one or more opioid permeable to the skin, 2) delivery means permeable to said opioid, 3) one or more antagonist for said opioid releasable upon ingestion or solvent immersion, and 4) impermeable barrier means separating said opioid and said antagonist.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully